Live Quote · NASDAQGNLXHealthcare· Biotechnology

Genelux Corporation

$2.17▼ 4.82%($-0.11)
MKT CAP $104.30MNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
42/100
▌ Weak
45
Valuation
20
Profitability
40
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNLX research report →

Analyst Price Target
$17.33+698.6% vs. today

Range $16 – $20

Analyst RatingBuy
2 Buy1 Hold0 Sell

Price Chart

-53.23% · this period
$5.59$3.71$1.82Nov 20May 26Nov 20
52-Week Range10% of range
Low
$1.77
Current
$2.17
High
$5.89